Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Rs11615 (C>T) in the Excision Repair Cross-complementing Group 1 Gene with Ovarian but not Gynecological Cancer Susceptibility: a Meta-analysis

  • Ma, Yong-Jun (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University) ;
  • Feng, Sheng-Chun (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University) ;
  • Hu, Shao-Long (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University) ;
  • Zhuang, Shun-Hong (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University) ;
  • Fu, Guan-Hua (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
  • Published : 2014.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Evidence suggests that the rs11615 (C>T) polymorphism in the ERCC1 gene may be a risk factor for gynecological tumors. However, results have not been consistent. Therefore we performed this meta-analysis. Methods: Eligible studies were identified by search of PubMed, MEDLINE and Chinese National Knowledge Infrastructure (CNKI). Odds ratios (ORs) and 95% confidence intervals (CIs) were applied to assess associations between rs11615 (C>T) and gynecological tumor risk. Heterogeneity among studies was tested and sensitivity analysis was applied. Results: A total of 6 studies were identified, with 1,766 cases and 2,073 controls. No significant association was found overall between rs11615 (C>T) polymorphism and gynecological tumors susceptibility in any genetic model. In further analysis stratified by cancer type, significantly elevated ovarian cancer risk was observed in the homozygote and recessive model comparison (TT vs. CC: OR=1.69, 95% CI=1.03-2.77, heterogeneity=0.876; TT vs. CT/CC: OR=1.72, 95% CI=1.07-2.77, heterogeneity=0.995). Conclusion: The results of the present meta-analysis suggest that there is no significant association between the rs11615 (C>T) polymorphism and gynecological tumor risk, but it had a increased risk in ovarian cancer.

Keywords

References

  1. Begg CB and Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  2. Chen M, Kamat AM, Huang M, et al (2007). High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis, 28, 2160-5. https://doi.org/10.1093/carcin/bgm167
  3. Chen P, Wiencke J, Aldape K, et al (2000). Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev, 9, 843-7.
  4. Cheng L, Eicher SA, Guo Z, et al (1998). Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev, 7, 465-8.
  5. DerSimonian R and Kacker R (2007). Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials, 28, 105-14. https://doi.org/10.1016/j.cct.2006.04.004
  6. Doherty JA, Weiss NS, Fish S, et al (2011). Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev, 20, 1873-82. https://doi.org/10.1158/1055-9965.EPI-11-0119
  7. Dunlop MG, Farrington SM, Carothers AD, et al (1997). Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet, 6, 105-10. https://doi.org/10.1093/hmg/6.1.105
  8. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  9. Friedberg EC (2001). How nucleotide excision repair protects against cancer. Nat Rev Cancer, 1, 22-33. https://doi.org/10.1038/35094000
  10. Goode EL, Ulrich CM and Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
  11. Guo SW and Thompson EA (1992). Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 48, 361-72. https://doi.org/10.2307/2532296
  12. Han SS, Kim JW, Lee SH, et al (2012). ERCC1 C19007T polymorphism and the risk and invasiveness of cervical cancer in Korean women. Asia Pac J Clin Oncol, 8, 63-7. https://doi.org/10.1111/j.1743-7563.2012.01586_2.x
  13. He SY, Xu L, Niu G, et al (2012). Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk. Asian Pac J Cancer Prev, 13, 1799-802. https://doi.org/10.7314/APJCP.2012.13.5.1799
  14. He X, Chang S, Zhang J, et al (2008). MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res, 36, 836-41.
  15. Hiyama T, Yoshihara M, Tanaka S, et al (2007). Genetic polymorphisms and esophageal cancer risk. Int J Cancer, 121, 1643-58. https://doi.org/10.1002/ijc.23044
  16. Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74. https://doi.org/10.1038/35077232
  17. Jo H, Kang S, Kim SI, et al (2007). The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Gynecol Obstet Invest, 64, 84-8. https://doi.org/10.1159/000100008
  18. Lau J, Ioannidis JP and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. https://doi.org/10.7326/0003-4819-127-9-199711010-00008
  19. Li FY, Ren XB, Xie XY, et al (2013). Meta-analysis of excision repair cross-complementation group 1 (ERCC1) association with response to platinum-based chemotherapy in ovarian cancer. Asian Pac J Cancer Prev, 14, 7203-6. https://doi.org/10.7314/APJCP.2013.14.12.7203
  20. Luo KQ, Mu SQ, Wu ZX, et al (2013). Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev, 14, 449-52. https://doi.org/10.7314/APJCP.2013.14.1.449
  21. Mantel N and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  22. Marin MS, Lopez-Cima MF, Garcia-Castro L, et al (2004). Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 13, 1788-93.
  23. Matullo G, Guarrera S, Sacerdote C, et al (2005). Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 14, 2569-78. https://doi.org/10.1158/1055-9965.EPI-05-0189
  24. Mort R, Mo L, McEwan C, et al (2003). Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer, 89, 333-7. https://doi.org/10.1038/sj.bjc.6601061
  25. Park JY, Lee SY, Jeon HS, et al (2002). Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 11, 23-7.
  26. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, et al (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem, 73, 39-85. https://doi.org/10.1146/annurev.biochem.73.011303.073723
  27. Shin A, Lee KM, Ahn B, et al (2008). Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev, 9, 501-5.
  28. Sturgis EM, Dahlstrom KR, Spitz MR, et al (2002). DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 128, 1084-8. https://doi.org/10.1001/archotol.128.9.1084
  29. Weiss JM, Weiss NS, Ulrich CM, et al (2005). Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev, 14, 2524-30. https://doi.org/10.1158/1055-9965.EPI-05-0414
  30. Xiong Y, Gu J, Zeng L, et al (2010). Association analysis between the DNA repair gene ERCC1 c19007t polymorphism and the pathogenesis of cervical cancer. JPractical Obstetrics and Gynecology, 26, 286-9.
  31. Zhou W, Liu G, Park S, et al (2005). Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 14, 491-6. https://doi.org/10.1158/1055-9965.EPI-04-0612

Cited by

  1. Lentivirus-Mediated RNAi Silencing Targeting ERCC1 Reverses Cisplatin Resistance in Cisplatin-Resistant Ovarian Carcinoma Cell Line vol.34, pp.7, 2015, https://doi.org/10.1089/dna.2015.2805
  2. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility vol.38, pp.3, 2018, https://doi.org/10.1042/BSR20180114